




The thesis entitled “Towards the Synthesis of Biologically Active Molecules: Zanamivir, Pinellic acid and (4R)–Dodecanolide” has been divided into four chapters.

Chapter-I: This chapter has been further divided into two sections.
Section A: This section deals with the introduction and previous synthetic approaches of Zanamivir. 
Section B: This section deals with the present work of Zanamivir. 
Chapter-II: This chapter has been divided into two sections.
Section A: This section deals with the introduction, previous synthetic approaches of Pinellic acid
Section B: This section deals with the present work of Pinellic acid. 
Chapter-III: This chapter has been divided into two sections.
Section A: This section deals with the introduction and previous synthetic approaches of (4R)-Dodecanolide.
Section B: This section deals with the present work of (4R)-Dodecanolide.
Chapter-IV: This chapter has been divided into two sections.
Section A: This sections deals with the brief review on BiCl3 and Imino Diels-Alder reactions. 
Section B: Stereoselective synthesis of octahydro-3b H-[1, 3] dioxolo [4'', 5'': 4', 5'] furo [2', 3': 5, 6] pyrano [4,3-b]- quinolines via intramolecular hetero-Diels-Alder reactions catalyzed by Bismuth (III) Chloride.

Chapter I: Towards the synthesis of Zanamivir





Zanamivir 1 inactivates viral influenza neuraminidase,1 an enzyme responsible for cleaving sialic acid residues on newly formed virions as they bud off from the host cell. This inhibition results in aggregation of virions on the surface of the host cell, which limits the extent of infection and speeds recovery from illness. Clinical studies have shown that neuraminidase inhibitors can decrease the median duration of influenza related symptoms by  1 day if initiated within 48 hours of the onset of symptoms of influenza. This section deals with the biological significance; clinical applications and gives brief account of the work carried out by the various research groups reported the total synthesis of Zanamivir.
Our synthetic strategy is based on the inexpensive starting material D-Sorbitol which has three hydroxyl groups having same configuration as in side chain of the target molecule and permits characterization of the intermediates with simple techniques such as NMR, IR and Mass etc.

Retrosynthetic strategy for Zanamivir





























































The compound 17 was protected as its methoxy methyl ether 6 by using iPr2EtN, and MOMCl in dry DCM at room temperature for 20 h in 80% yield4 (Scheme 2). The ring opening of the epoxide 6a with alkyne 6 using n-BuLi (1.6 M, in hexane) and BF3.Et2O (Yamaguchi’s method) in dry THF at -78oC to gave the coupled product 5 in 70% yield.5 Controlled hydrogenation of the alkyne 5 to its cis alkene compound 18 in 90% yield, was achieved by using Pd/CaCO3 and quinoline (Lindlar’s catalyst) in EtOAc under H2 gas. 




















The compound 4 was converted to bromohydrin 21 (Dalton and Dutta method) as a single isomer by treating with NBS, water in DMSO at –10oC in 70% yield8 (Scheme 3). The base mediated cyclization of bromohydrin 21 using K2CO3 in MeOH at room temperature for 4 h furnished the epoxide 22 in 80% yield (Scheme 3). The epoxide 22 when opened by azide functionality using NaN3 and aq DMF at 125oC for 2 h afforded the mixture of regioisomers of azido alcohols 23 and 24 in 70% yield 9(Scheme 3). Generally nucleophile attacks from less hindered side, but in this case azide ion attacked abnormally and resulted in 70% yield of 23 and in 30% yield of 24. The secondary hydroxyl groups of azido alcohols 23 and 24 were converted as their mesylates 25 and 26 respectively in 90% yield using MeSO2Cl and TEA in dry DCM at 0oC. The stereochemistry of azide and –OMs groups were characterized by nOe studies. Mesylazide compounds 25 and 26 were treated with TPP and iPr2EtN in aq THF at reflux temperature to give aziridine 27 in 85% yield. The ring opening of the aziridine 27 was demonstrated with sodium azide and aq DMF at 125oC. After purification the compound was acetylated with acetic anhydride, Et3N and catalytic amount of DMAP in dry DCM to get 3 in 70% yield (Scheme 3). The ring opening of aziridine 27, unlike epoxide 22 as indicated by nOe studies underwent nuceleophile attack from less hindered side. Nucleophilic attack from more hindered side would have resulted in desired stereochemistry to complete the synthesis of Zanamivir effectively, efforts are still on for the total synthesis of Zanamivir. 

Chapter II: Total synthesis of Pinellic acid 







	Among the C-9-isomer of Pinellic acid, 9S-compound showed much stronger activity compared with 9R-compounds. Thus stereochemistry at the C-9 hydroxyl group is very important for adjuvant activity. Among the 9S-derivatives, the adjuvant activities of 13S-compounds are stronger than that of 13R-compounds. However, the stereochemistry of the C-12 hydroxyl group is not important for adjuvant activity.
Retrosynthetic strategy for Pinellic acid













Construction of the C12-C18 fragment 















Compound 38 were converted into a secondary allylic alcohol 39 in 80% yield by refluxing with activated zinc and sodium iodide in dry methanol.13 The allylic compound 39 was converted into methoxy methyl ether 40 in 90% yield using Hunig’s base iPr2NEt and MOMCl for 2 h at room temperature. The compound 40 was subjected to ozonolysis to give the required aldehyde 31 in 80% yield (Scheme 4). 

Construction of C1-C11 fragment












Coupling of C1-C11 and C12-C18 fragments
































The secondary hydroxyl functionality of compound 46 was protected as its methoxy methyl ether using Hunig’s (iPr2EtN) base and MOMCl in dry DCM at room temperature to afford the compound 47 in 90% yield. THP deprotection of 47 was carried out by using PPTS in methanol to afford the compound 48 in 80% yield.14 The compound 48 was oxidized with DMP in DCM to afford the aldehyde 49 in 85% yield (Scheme 6). The compound 49 was further oxidized with NaClO2 and NaH2PO4 in DCM to afford the corresponding acid 50 in 79% yield.15 Finally deprotection of three MOM groups by using 6 N HCl to afforded the target molecule 28 in 70% yield (Scheme 6).

Chapter III: Total synthesis of (4R)-Dodecanolide





 	(4R)-Dodecanolide is a pheromone component, which was isolated from the pygidal glands of rove beetles Bledius mandibularies and Bledius spectabilis by Wheeler et al. 
Retrosynthetic route of (4R)-Dodecanolide
























Acetylenic alcohol 56 was reduced with LiAlH4 in refluxing dry THF to afford the trans-allylic alcohol 57 in 85% yield The E- allyl alcohol 57 was subjected to the Sharpless asymmetric epoxidation protocol. Accordingly, treatment of compound 57 with D (-) DET, 0.2 eq of Ti (OiPr)4 and TBHP (3.3 M in toluene) in dry DCM at -24oC afforded the epoxy alcohol 58 in 85% yield. The epoxy alcohol 58 was converted to corresponding epoxy chloride 59 in 90% yield by using TPP and NaHCO3, in dry CCl4 on refluxing for 4 h. Accordingly, compound 59 was subjected to LiNH2 in liquid ammonia to get the chiral propargyl alcohol 60 in 76% yield (Scheme 7). The secondary hydroxyl functionality of 60 was protected as its methoxy methyl ether using Hunig’s base (iPr2EtN) and MOMCl in dry DCM at room temperature to afford 53 in 90% yield (Scheme 7). The acetylene 53 was subjected to methoxy carbonylation in presence of 1 eq of n-BuLi (1.6 M in Hexane) and 1 eq of 54 at -78oC to give the compound 61 in 90% yield.17 The ester 61 was reduced with 10% Pd/C under hydrogen atmosphere to get the saturated ester 52 in 90% yield (Scheme 7). Finally the Cyclization of 2 with PTSA in methanol afforded 51 in 85% yield (Scheme 7). 

Chapter IV: BiCl3 Catalyzed Intramolecular imino Diels-Alder reactions.
Stereoselective synthesis of octahydro-3b H-[1, 3] dioxolo [4'', 5'': 4', 5'] furo [2', 3': 5, 6] pyrano [4,3-b]- quinolines via intramolecular hetero-Diels-Alder reactions catalyzed by Bismuth (III) Chloride.
The chemistry of tetrahydroquinoline derivatives has been long area of intense for organic chemists due to presence of these scaffolds within the framework of numerous biologically interesting natural products and pharmaceutical agents. The most attractive strategy for these derivatives is the acid-promoted imino-Diels-Alder reaction between N-arylaldimines and electron rich alkenes. 
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